A Phase 1 Comparative Study of E2022 Current and New Patch Formulations
Latest Information Update: 29 Jan 2014
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Sponsors Eisai Co Ltd
- 29 Jan 2014 New trial record